STAT3 and head and neck squamous cell carcinoma: Oweida et al. (2018) previously demonstrated that Tregs are highly enriched in orthotopic models of HNSCC and contribute to treatment resistance, also they found that STAT3 inhibition is a viable and potent therapeutic target against Tregs (Oweida et al., 2019).